Advertisement
Corus Entertainment Inc.

Stay Updated with the Latest Corus Entertainment Inc. CJR-B.TO News in Real Time

Find CJR-B.TO news now at Meyka AI. Stay informed with the latest Corus Entertainment Inc. stocks updates, including price news, market analysis, and expert insights.

CJR-B.TOTSX
$0.03
$0.00(0.00%)
Canadian Market is Open · 13:31
Advertisement
Take-Two Sets GTA VI Release for PS5 and Xbox Series X|S on November 19, 2026 at $79.99 
📅 in 3 minutes

Take-Two Sets GTA VI Release for PS5 and Xbox Series X|S on November 19, 2026 at $79.99 

GTA VI has a firm price and a launch date. Take-Two Interactive confirmed on June 24, 2026, that Grand Theft Auto VI will launch on November 19 at $79.99 for PS5 and Xbox Series X|S. TTWO stock climbed roughly 3% in premarket trading after the announcement, with Bank of America simultaneously raising its price target…

Read more 12
Nike Inc (NYSE: NKE) Stock Drops Ahead of Q4 Earnings as Surprise CFO Change Raises Turnaround Questions
📅 5 hours ago

Nike Inc (NYSE: NKE) Stock Drops Ahead of Q4 Earnings as Surprise CFO Change Raises Turnaround Questions

Nike Inc chose the worst possible timing for a leadership change. Nike Inc (NYSE: NKE) announced on June 23, 2026, that CFO Matthew Friend will step down effective August 17, to be replaced by David M. Denton as incoming Chief Financial Officer. NKE traded near $45.20 as of June 15, already 44% below its 52-week…

Read more 12
New Zealand shares -0.26% S&P/NZX 50 Index, Nvidia -4%, AMD -6% Nasdaq Composite -2%, S&P 500 -1%
📅 6 hours ago

New Zealand shares -0.26% S&P/NZX 50 Index, Nvidia -4%, AMD -6% Nasdaq Composite -2%, S&P 500 -1%

Global markets faced fresh pressure on June 24, 2026, as a sharp selloff in semiconductor stocks rattled investor sentiment. NVIDIA fell around 4%, while AMD dropped nearly 6%, dragging the Nasdaq Composite down about 2% and the S&P 500 lower by 1%.  The weakness also spread to Asia, with New Zealand’s S&P/NZX 50 Index slipping…

Read more 12
Qualcomm Inc (NASDAQ: QCOM) Loses 1.86% to $221.90 as AI Expansion Gains Momentum but Stock Faces Pressure
📅 1 day ago

Qualcomm Inc (NASDAQ: QCOM) Loses 1.86% to $221.90 as AI Expansion Gains Momentum but Stock Faces Pressure

Qualcomm Inc (NASDAQ: QCOM) pulled back 1.86% to $221.90 on June 23, 2026, even as its AI and automotive expansion story grows more concrete by the quarter. The stock trades within a 52-week range of $121.99 to $259.92, reflecting a sharp recovery from lows but still well off its all-time closing high of $250.10 from…

Read more 12
Tesla Inc Shares (NASDAQ: TSLA) up +1.14% After Jefferies Lowers Target to $375 Amid SpaceX Merger Talk
📅 1 day ago

Tesla Inc Shares (NASDAQ: TSLA) up +1.14% After Jefferies Lowers Target to $375 Amid SpaceX Merger Talk

Tesla Inc. shares climbed 1.14% after analysts at Jefferies lowered their price target to $375, drawing fresh attention to the company’s future growth path. The move comes as investors closely watch rising speculation about a possible Tesla-SpaceX merger, a topic that has sparked intense debate across Wall Street in June 2026. While some see major…

Read more 12
Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029
📅 2 days ago

Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029

Robinhood shares dropped roughly 4% on June 22, 2026, after the company announced a major capital raise before market open. Robinhood Markets, Inc. (NASDAQ: HOOD) intends to offer $2.0 billion in convertible senior notes due 2029 in a private placement to qualified institutional buyers under Rule 144A. Shares traded at $108.15 on June 22, within…

Read more 12
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
📅 2 days ago

AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium

AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…

Read more 12
CRH Eyes $8 Billion Arcosa Acquisition, Potential Deal Values Target at 13.7x EBITDA
📅 2 days ago

CRH Eyes $8 Billion Arcosa Acquisition, Potential Deal Values Target at 13.7x EBITDA

CRH made its biggest-ever acquisition official on June 22, 2026, signing a definitive agreement to acquire Arcosa, Inc. (NYSE: ACA) in an all-cash transaction. CRH will pay $150 per share in cash, with the transaction valuing Arcosa at a total enterprise value of approximately $8.5 billion, representing an acquisition multiple of 11.5x 2026E Adjusted EBITDA,…

Read more 12
Tesla Inc (TSLA) +1.04%: Jefferies Revises Down Target, Highlights SpaceX Tracking Stock Risk
📅 2 days ago

Tesla Inc (TSLA) +1.04%: Jefferies Revises Down Target, Highlights SpaceX Tracking Stock Risk

Tesla Inc (TSLA) traded higher by about 1% in recent sessions in June 2026, even as Wall Street turned cautious. In a fresh note, Jefferies revised its price target lower and flagged new concerns around valuation pressure. The report also pointed to growing risks linked to SpaceX-related tracking stock sentiment and Elon Musk’s wider business…

Read more 12

CJR-B.TO News FAQ